U.S. Industrial REITs Stock News

NasdaqGS:PHAT
NasdaqGS:PHATPharmaceuticals

A Look At Phathom Pharmaceuticals (PHAT) Valuation After Narrower Losses And Reaffirmed Profitability Timeline

Phathom Pharmaceuticals (PHAT) recently reported first quarter results showing a net loss of US$30.37 million, alongside reaffirmed 2026 guidance that includes an operating profitability target beginning in the third quarter. See our latest analysis for Phathom Pharmaceuticals. The stock’s recent 12.62% 1 month share price return, alongside a 7.56% 7 day gain, contrasts with a 19.35% year to date share price decline. At the same time, the 1 year total shareholder return above 400% highlights...
NYSE:HL
NYSE:HLMetals and Mining

Hecla Mining (HL) Q1 EPS Surge Tests Bullish Margin Narrative

Hecla Mining (HL) earnings snapshot Hecla Mining (HL) has put fresh numbers on the table for Q1 2026, with revenue of US$411.4 million, basic EPS of US$0.25 and net income from continuing operations of US$164.5 million, while also reporting earnings from discontinued operations of US$183.7 million. Over the past year, the company has seen revenue move from US$929.9 million on a trailing basis to US$1.57 billion and EPS shift from US$0.06 to US$0.69, alongside a very large year over year...
NasdaqGS:LCID
NasdaqGS:LCIDAuto

Lucid Group (LCID) Q4 Loss Of US$1.18b Tests Bullish Margin Improvement Narrative

Lucid Group (LCID) has just wrapped up FY 2025 with fourth quarter revenue of US$522.7 million, a basic EPS loss of US$3.62, and net income loss of US$1.18 billion. The trailing twelve month figures show revenue of US$1.35 billion and a basic EPS loss of US$11.81. The company’s revenue has moved from US$807.8 million on a trailing basis at the end of 2024 to US$1.35 billion by the end of 2025. EPS has remained deeply negative over the same stretch, setting up a results season in which...
NYSE:AIZ
NYSE:AIZInsurance

Assurant (AIZ) Q1 EPS Beat Strength Narrative Of Margin Stability And Earnings Quality

Assurant (AIZ) kicked off 2026 with Q1 revenue of US$3.4 billion and basic EPS of US$5.51, alongside net income excluding extra items of US$274.1 million, setting a clear marker for how the year is starting to shape up. Over recent quarters the company has seen revenue move from US$3.1 billion in Q1 2025 to US$3.4 billion in Q1 2026. Basic EPS has ranged between US$2.86 and US$5.23 in 2025 before reaching US$5.51 this quarter, giving you a clear view of how the income line has been tracking...
NYSE:JXN
NYSE:JXNDiversified Financial

Jackson Financial Q1 EPS Loss Deepens Challenging Bullish Margin Narratives

Jackson Financial's Q1 2026 Numbers Set the Stage for a Margin Story Jackson Financial (JXN) has opened 2026 with Q1 revenue of about US$2.9 billion and a basic EPS loss of US$6.24, alongside a trailing twelve month EPS loss of US$5.94 and net income loss of US$417 million. The company has seen quarterly revenue range from US$245 million in Q4 2024 to US$3.8 billion in Q1 2025. Basic EPS has swung between a profit of US$4.50 in Q4 2024 and the current Q1 2026 loss, which puts investor...
NasdaqGS:AZTA
NasdaqGS:AZTALife Sciences

Azenta (AZTA) Quarterly Loss Of US$157 Million Reinforces Bearish Margin Narratives

Azenta (AZTA) has put a tough quarter on the table, with Q2 2026 revenue of US$144.8 million and a basic EPS loss of US$3.41, alongside net income from continuing operations showing a loss of US$157.0 million. The company has seen quarterly revenue move from US$143.4 million in Q2 2025 to US$158.0 million in Q4 2025 and then to US$144.8 million in Q2 2026. EPS has swung from a loss of US$0.40 in Q2 2025 to a profit of US$1.12 in Q4 2025 and back to a loss of US$3.41 in the latest quarter,...
NasdaqGS:RIGL
NasdaqGS:RIGLBiotechs

Rigel Pharmaceuticals (RIGL) Q1 EPS Compression Tests Bullish High‑Earnings Narrative

Rigel Pharmaceuticals (RIGL) opened 2026 with Q1 revenue of US$58.8 million and basic EPS of US$0.47, alongside trailing 12‑month revenue of US$299.8 million and basic EPS of US$20.08, set against very large year over year earnings growth and higher net profit margins in the latest trailing figures. Over recent quarters the company has seen revenue move from US$57.6 million in Q4 2024 to US$53.3 million in Q1 2025, US$101.7 million in Q2 2025, US$69.5 million in Q3 2025 and US$69.8 million in...
NasdaqGS:DUOL
NasdaqGS:DUOLConsumer Services

Duolingo (DUOL) Q1 Margin Strength Tests Bullish Profit Sustainability Narratives

Q1 2026 earnings snapshot Duolingo (DUOL) opened 2026 with Q1 revenue of US$292.0 million and basic EPS of US$0.93, setting the tone for the latest results at a share price of US$105.02. Over the past year, the company has seen revenue move from US$230.7 million in Q1 2025 to US$292.0 million in Q1 2026, while basic EPS shifted from US$0.78 to US$0.93, against a trailing twelve month EPS figure of US$9.14. With trailing net profit margins now framed by a much higher earnings base, the story...
NYSE:MCY
NYSE:MCYInsurance

Mercury General (MCY) Wildfire Combined Ratio Swings Challenge Underwriting Stability Narratives

Mercury General (MCY) closed out FY 2025 with Q4 revenue of US$1.5 billion and basic EPS of US$3.66, supported by trailing twelve month revenue of US$6.0 billion and EPS of US$9.77. Over the past few quarters, revenue has moved from US$1.39 billion in Q1 2025 to US$1.54 billion in Q4 2025, while quarterly EPS has ranged from a loss of US$1.96 in Q1 2025 to a high of US$5.06 in Q3 2025. These figures provide context for investors assessing recent net income of US$202.5 million alongside a more...
NYSE:LDOS
NYSE:LDOSProfessional Services

Leidos Holdings (LDOS) Net Margin Near 8.2% Tests Slower Earnings Growth Narratives

Leidos Holdings (LDOS) opened 2026 with Q1 revenue of US$4.4b and basic EPS of US$2.60, alongside trailing 12 month revenue of US$17.3b and EPS of US$11.13 that sit against a 8.2% net margin, up from 7.9% a year earlier. Over the past year, earnings growth of 6.1% has run below the five year average of 18.1%. This puts more weight on how investors read the balance between steady profit generation and the current margin profile. Overall, the latest numbers point to a business where...
NasdaqCM:NUTX
NasdaqCM:NUTXHealthcare

Nutex Health (NUTX) Is Up 5.1% After Strong Q1 Results And New Buyback Plan - What's Changed

Nutex Health reported past first-quarter 2026 results on April 30, with revenue of US$216.49 million and net income of US$46.81 million, lifting both basic and diluted earnings per share from continuing operations versus a year earlier. Alongside these results, the company announced a second US$25.00 million share repurchase program and a shift toward directly developing new hospital facilities, signaling a material change in how it funds and expands its footprint. We’ll now examine how...
NYSE:FERG
NYSE:FERGTrade Distributors

Ferguson (FERG) Q1 2026 Margin Gains Test Bullish Earnings Narratives

Ferguson Enterprises Q1 2026 headline numbers Ferguson Enterprises (FERG) opened fiscal Q1 2026 with revenue of about US$7.5b and basic EPS of US$2.13, setting a clear marker for how the business is starting the new financial year. The company has seen quarterly revenue move from roughly US$7.2b in Q1 2025 to about US$7.5b in Q4 2025 and then US$7.5b in Q1 2026. Basic EPS has shifted from US$1.74 to US$1.99 and then US$2.13 over the same periods, giving investors a view on how earnings are...
NYSE:JBTM
NYSE:JBTMMachinery

JBT Marel (JBTM) Quarterly Profit Of US$53.1m Tests Bearish Loss-Narrative

JBT Marel (JBTM) has just put fresh numbers on the table for Q1 2026, coming off Q4 2025 revenue of about US$1.0 billion and basic EPS of US$1.02, against a trailing twelve month picture that includes a basic EPS loss of US$0.96 on US$3.8 billion of revenue. Over the past few quarters, the company has seen quarterly revenue move from US$453.8 million in Q3 2024 to US$854.1 million in Q1 2025 and then to roughly US$1.0 billion by Q4 2025. EPS swung from US$1.19 in Q3 2024 to a loss of US$3.35...
NYSE:NRG
NYSE:NRGElectric Utilities

Is It Time To Revisit NRG Energy (NRG) After Its Strong Five Year Share Price Gain

With NRG Energy last closing at US$150.64, this article looks at whether the stock is still priced for opportunity or already reflects most of its story, and what that may mean for you as an investor. The stock has returned 1.1% over the last 7 days and 0.6% over the last 30 days, with a year-to-date decline of 9.3% and a 28.4% return over the last year, alongside a very large gain over 5 years. Recent coverage has focused on NRG Energy's position within the US utilities sector and how its...
NYSE:FND
NYSE:FNDSpecialty Retail

Is It Time To Reconsider Floor & Decor (FND) After A 30% One Year Share Price Drop

If you are wondering whether Floor & Decor Holdings at around US$51 a share is attractively priced or a potential value trap, the starting point is understanding how the current market price lines up against different measures of value. The stock has recently moved 7.0% over the last week and 3.3% over the last month, while the year to date return sits at a 19.0% decline and the 1 year return at a 30.5% decline, which may catch the eye of investors weighing up risk and recovery...
NYSE:IT
NYSE:ITIT

Gartner (IT) Margin Reset To 11.2% Reinforces Bearish Profitability Narratives

Gartner (IT) has put fresh numbers on the board for Q1 2026, reporting revenue of US$1.5b and basic EPS of US$3.19 off net income of US$222.3m, setting the tone for how you might think about the rest of the year. Over recent quarters the company has seen revenue move between US$1.5b and US$1.8b, while quarterly EPS has ranged from US$0.47 to US$5.14, providing a clear view of how earnings power has fluctuated into this latest print. With trailing net margins now sitting well below last year’s...
NYSE:SMR
NYSE:SMRElectrical

Is NuScale Power (SMR) Pricing In Nuclear Policy Support Despite Mixed Long Term Returns

If you are wondering whether NuScale Power's current share price reflects its true worth, this article will help you size up the stock using several valuation tools. The stock recently closed at US$11.87, with returns of 0.4% over 7 days, 16.9% over 30 days, a 27.2% decline year to date, a 32.8% decline over 1 year, 47.6% over 3 years and 19.8% over 5 years. This gives you a wide range of outcomes to think about. Recent coverage has focused on NuScale Power's role in nuclear energy...
NasdaqGS:ALKS
NasdaqGS:ALKSBiotechs

Alkermes (ALKS) Margin Compression Tests Bullish Earnings Growth Narratives Ahead Of Q1 2026

Alkermes Q1 2026 earnings: setting the stage Alkermes (ALKS) heads into Q1 2026 following its Q4 2025 report, where revenue was US$384.5 million and basic EPS came in at US$0.30, with net income excluding extra items of US$49.3 million. Over recent quarters, the company has reported revenue of US$429.99 million in Q4 2024, US$390.7 million in Q2 2025, and US$394.2 million in Q3 2025. Quarterly basic EPS over that period was US$0.90 in Q4 2024, US$0.50 in Q3 2025, and US$0.30 in Q4 2025. These...
NYSE:RVTY
NYSE:RVTYLife Sciences

Revvity (RVTY) Net Margin Deterioration Tests Bullish Recovery Narratives Ahead Of Q1 2026

Revvity Q1 2026 earnings snapshot Revvity (RVTY) has just put fresh numbers on the table, with recent quarters showing revenue between US$664.8 million and US$772.1 million and basic EPS ranging from US$0.35 to US$0.85 as the company heads into its Q1 2026 update. Over the past year, revenue has been recorded from US$684.0 million in Q3 2024 up to US$772.1 million in Q4 2025, while basic EPS prints in that stretch run from US$0.35 to US$0.85, giving investors a clear view of how the top line...
NYSE:ALLY
NYSE:ALLYConsumer Finance

Is It Too Late To Consider Ally Financial (ALLY) After A 36.8% One Year Gain?

Wondering if Ally Financial at around US$43 per share still offers value, or if most of the easy gains are behind it, starts with understanding what the current price is actually reflecting. The stock has had mixed recent returns, with a 2.7% decline over the last week, an 8.5% gain over the last month, a 5.6% decline year to date, and a 36.8% return over the last year alongside an 88.9% three year return and a 2.9% five year decline. Recent coverage has focused on how Ally Financial fits...
NYSE:AVA
NYSE:AVAIntegrated Utilities

Avista (AVA) Margin Improvement Tests Bullish Narratives Ahead Of Q1 2026 Earnings

Avista’s Q1 2026 earnings in focus Avista (AVA) has rolled into Q1 2026 on the back of a solid run through 2025, capped by Q4 revenue of US$533 million and basic EPS of US$0.87, alongside trailing 12 month EPS of US$2.38 on US$1.96 billion of revenue. Over recent quarters, the company has seen revenue hold in a US$394 million to US$617 million range while quarterly EPS moved between US$0.17 and US$0.98. The trailing net profit margin is 9.8% compared with 9.3% a year earlier, which puts the...
NYSE:AGCO
NYSE:AGCOMachinery

AGCO (AGCO) Profit Rebound And Low P/E Challenge Bearish Earnings Narratives

AGCO (AGCO) has just opened Q1 2026 earnings season with recent quarterly numbers that plot a sharp swing in profitability, moving from a Q4 2024 net loss of US$255.7 million on US$2,887.3 million of revenue and EPS of US$3.43 loss, to Q4 2025 net income of US$95.5 million on US$2,920.2 million of revenue and EPS of US$1.29. Over the same period, trailing twelve month EPS shifted from a US$5.69 loss on US$11.7 billion of revenue to US$9.76 on US$10.1 billion. Revenue moved from US$2,599.3...
NYSE:COP
NYSE:COPOil and Gas

Is It Too Late To Reassess ConocoPhillips (COP) After Its Recent Strong Share Price Run?

Investors may be wondering if ConocoPhillips at around US$123.32 still offers value after a strong run, or if recent enthusiasm has already been priced in. The stock has seen a 27.5% return year to date and 45.5% over the last year, even though the last 7 days and 30 days showed returns of a 0.8% decline and a 5.5% decline, respectively. Recent coverage has focused on ConocoPhillips as a major integrated energy producer, with attention on how it is positioning its portfolio and capital...
NasdaqGS:ANAB
NasdaqGS:ANABBiotechs

How Do AnaptysBio’s (ANAB) Jemperli Royalties Shape Its Investment Case After Tesaro’s Claim Dismissal?

AnaptysBio recently reported that the Delaware Chancery Court dismissed Tesaro’s anticipatory breach of contract claim over their Jemperli collaboration, while CEO Daniel Faga is set to discuss the company’s royalty assets at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference on May 6, 2026. This legal outcome, combined with a stronger earnings outlook highlighted by an upgraded Zacks rank, strengthens AnaptysBio’s position around its Jemperli-related royalty rights. We’ll now...